Total Current Assets - Gensight Biologics SA (PAR:SIGHT) - Alpha Spread

Gensight Biologics SA
PAR:SIGHT

Watchlist Manager
Gensight Biologics SA Logo
Gensight Biologics SA
PAR:SIGHT
Watchlist
Price: 0.38 EUR -3.8%
Market Cap: 39.3m EUR
Have any thoughts about
Gensight Biologics SA?
Write Note

Gensight Biologics SA
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gensight Biologics SA
Total Current Assets Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Gensight Biologics SA
PAR:SIGHT
Total Current Assets
€6.5m
CAGR 3-Years
-47%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Total Current Assets
€269.2m
CAGR 3-Years
-22%
CAGR 5-Years
17%
CAGR 10-Years
16%
Nanobiotix SA
PAR:NANO
Total Current Assets
€87.3m
CAGR 3-Years
-11%
CAGR 5-Years
15%
CAGR 10-Years
29%
Innate Pharma SA
PAR:IPH
Total Current Assets
€111.6m
CAGR 3-Years
-5%
CAGR 5-Years
-12%
CAGR 10-Years
2%
Genfit SA
NASDAQ:GNFT
Total Current Assets
€113.1m
CAGR 3-Years
-15%
CAGR 5-Years
-12%
CAGR 10-Years
15%
Eurobio Scientific SA
PAR:ALERS
Total Current Assets
€143.9m
CAGR 3-Years
2%
CAGR 5-Years
35%
CAGR 10-Years
25%

See Also

What is Gensight Biologics SA's Total Current Assets?
Total Current Assets
6.5m EUR

Based on the financial report for Dec 31, 2023, Gensight Biologics SA's Total Current Assets amounts to 6.5m EUR.

What is Gensight Biologics SA's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
-29%

Over the last year, the Total Current Assets growth was -72%. The average annual Total Current Assets growth rates for Gensight Biologics SA have been -47% over the past three years , -29% over the past five years .

Back to Top